July 24,2024

Admin

Health Benefits


Recent studies are highlighting the unexpected benefits of GLP‑1-based medications like semaglutide and tirzepatide. Beyond just weight reduction, these drugs appear to improve heart function, reduce inflammation, and lower the risk of conditions like sleep apnoea and fatty liver disease. One groundbreaking study, SELECT, found that semaglutide reduced the risk of heart attack and stroke even in non-diabetics. Researchers are now investigating how these jabs may influence cancer risk and cognitive decline. The longevity impact is still being explored, but early data is encouraging. For patients with obesity-related health concerns, these injections represent not just a cosmetic fix — but potentially a life-extending treatment backed by science.